Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assumption of Sylimarin, Pyrroloquinoline, Quinone Sodium Salt and Myricetin: Effects on Alcohol Levels and Markers of Oxidative Stress

NCT06548503 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.

NCT NCT06548503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06548503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assumption of Sylimarin, Pyrroloquinoline, Quinone Sodium Salt and Myricetin: Effects on Alcohol Levels and Markers of Oxidative Stress
Lead sponsor
University of Padova
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2023
Completion date
March 31, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol drinking, oxidative stress